Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept & continue
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Vladimir Putin annexes four Ukrainian regions
    • Military briefing: Ukraine forces close to encircling Russian troops in key town
    • Russia withdraws from key eastern city of Lyman as Ukrainians advance
    • Lael Brainard signals Fed concern over emerging market vulnerabilities
    • Europe increases defence of energy assets after Baltic Sea ‘sabotage’
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • Inside the breakdown of the UK’s mortgage machine
      • Prestigious Hong Kong flats stand empty as property market slumps
      • Elon Musk unveils Tesla’s humanoid robot prototype
      • McKinsey charged over role in South Africa’s ‘state capture’ scandal
      • BlackRock threatened to halt trading at height of UK market tumult
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Seven days that shook the UK
      • UK pension funds sell assets and tap employers in rush for cash
      • UK watchdogs hold crisis talks to avert gilts cliff-edge
      • US stocks record longest run of quarterly declines since 2008 crisis
      • Sterling almost erases losses from Kwasi Kwarteng’s mini-Budget
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
      Most Read
      • For a fascist revival look to Moscow, not Rome
      • Outlier Britain needs a credible economic plan in a hurry
      • The ‘chip choke’ on China may breathe air into semiconductor industry
      • The week that wrecked our personal finances
      • This is Keir Starmer’s moment — but victory is not yet assured
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • Carlo Rovelli: ‘Science is not just about writing equations. It’s about reconceptualising the world’
      • Mars’ outgoing CEO on succession, family businesses and eating his own dog food
      • Talent wars: why businesses have to battle to hire the best
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • Everything must go – Pharrell Williams is selling off his legacy
      • Hong Kong’s expat party continues — but for how long?
      • Katherine Rundell: ‘Larger than the world’s chaos are its miracles’
      • The art and science of picking winning teams
      • Summer is over. But the UK is unprepared for the heatwaves to come
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Clive Cookson

    Science editor
    As FT science editor, Clive Cookson covers the whole span of science worldwide, from medicine and biology to physics and space exploration, including research funding and policy issues. He worked previously as science correspondent for BBC Radio.
    Email Clive Cookson @clivecookson  on Twitter (link opens in a new browser window)
    Email Clive Cookson @clivecookson  on Twitter (link opens in a new browser window)

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Tuesday, 27 September, 2022
      Space exploration
      Nasa successfully smashes satellite into asteroid in first deflection mission

      Dart strikes target 11mn km away in test of new technology to protect Earth from future threats

    • Wednesday, 21 September, 2022
      Pharmaceuticals sector
      Biogen drug slows progress of motor neurone disease in landmark trial

      Tofersen targets a defective gene that causes about 2% of cases of MND, also known as amyotrophic lateral sclerosis

    • Wednesday, 21 September, 2022
      Quantum technologies
      Danish initiative aims to develop first quantum computer for life sciences

      Novo Nordisk Foundation to spend $200mn over seven years on superfast devices for biomedical research

    • Sunday, 18 September, 2022
      The Big Read
      The race to reinvent the space station

      Nasa is funding American companies to build commercial replacements for the trailblazing International Space Station

    • Tuesday, 13 September, 2022
      Medical science
      UK university develops device to restore sense of touch to stroke patients

      Technology unveiled at British Science Festival brings back sensation by stimulating fingertips

    • Saturday, 10 September, 2022
      Pollution
      Scientists discover how air pollution causes lung cancer

      New techniques to prevent and treat tumours could be developed after researchers identify role played by inflammation

    • Thursday, 8 September, 2022
      Coronavirus pandemic
      Scientists seek $100mn to research long Covid

      Ethereum co-founder among those funding work on debilitating after effects of virus

    • Thursday, 25 August, 2022
      Scientific research
      Scientists create ‘synthetic’ mouse embryos with brains and beating hearts

      Aim is to use stem cell research to help humans in areas ranging from fertility treatment to organ transplants

    • Monday, 22 August, 2022
      Medical science
      Electrical brain stimulation improves memory in elderly, research finds

      Study could be used to help boost cognitive performance of people developing Alzheimer’s disease

    • Thursday, 18 August, 2022
      Pollution
      Scientists discover process to destroy harmful ‘forever chemicals’

      Chemists break down fluorine compounds that pose a global pollution problem and health risk

    • Wednesday, 17 August, 2022
      Coronavirus pandemic
      Covid can cause brain disorders two years after infection, study shows

      Long-term effects are generally less in children, although infection doubles risk of epilepsy

    • Sunday, 14 August, 2022
      Biotech
      Cambridge start-up aims to rewrite the code of life

      Constructive Bio plans to reprogramme microbes to make new materials from drugs to biodegradable plastics

    • Sunday, 14 August, 2022
      The Big Read
      How science is getting closer to a world without animal testing

      New technology involving miniature human organs built in a lab is a step towards better treatments and ending a contentious practice

    • Wednesday, 10 August, 2022
      Racial equality
      Wellcome vows action to counter its ‘institutional racism’

      Medical charity will introduce funding stream aimed at black and minority researchers

    • Wednesday, 3 August, 2022
      Science
      UK’s ‘science superpower’ goal will fail without change in strategy, warn reports

      House of Lords committee and think-tank separately urge new PM to focus on results and invest more in R&D

    • Wednesday, 3 August, 2022
      Medical science
      Scientists revive cells and tissues in dead pigs

      Yale research could expand donor organ availability but blurs boundary between life and death

    • Friday, 15 July, 2022
      Special ReportHydrogen — Fantasy or fuel of the future?
      Fuel cells show greatest promise in aviation

      Aerospace companies are working on parallel projects to burn hydrogen in modified jet engines

    • Tuesday, 12 July, 2022
      Space exploration
      Webb telescope images reveal dance of ancient galaxies

      New pictures released as part of $10bn collaboration come as space agencies hail ‘dawn of a new era in astronomy’

    • Sunday, 3 July, 2022
      Covid-19 vaccines
      Covid vaccines: how can immune imprinting help experts to rethink jabs?

      More than two years into the pandemic, people have acquired different levels of immunity through infections and shots

    • Saturday, 2 July, 2022
      Science
      UK science minister in dispute with Treasury over post-Brexit funding

      Plan for an alternative to EU’s flagship Horizon project has yet to win finance ministry’s agreement

    • Friday, 1 July, 2022
      Coronavirus pandemic
      Omicron variants drive 34% jump in England’s Covid infections

      Scotland remains the nation hit hardest by the surge, according to the ONS

    • Friday, 1 July, 2022
      Science
      Cern scientists restart hunt for answers to mysteries of universe

      Large Hadron Collider fired up again after three-year shutdown to boost its power and precision

    • Wednesday, 29 June, 2022
      Q&ACoronavirus pandemic
      How worried should we be about new Covid variants?

      FT science editor Clive Cookson and global pharma correspondent Hannah Kuchler answered your questions about rising Omicron infections and vaccine efficiency

    • Monday, 27 June, 2022
      Covid-19 vaccines
      Pause in medication would improve Covid jab response for millions, study shows

      Short break in immune suppression treatment improves antibody production after vaccination while doing little harm

    • Friday, 24 June, 2022
      Coronavirus pandemic
      Covid infections rise 20% in England as new Omicron variants spread

      Scotland hit hardest in the UK as cases climb 40% to leave one in 20 people suffering from the disease

    Previous page You are on page 1 Next page

    Be part of FT Community

    Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

    FT LiveGlobal Pharma and Biotech SummitDriving Investment and Innovation in Life Sciences
    Monday, 7th NovemberLondon, UK & Online
    Learn more about FT Community

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT LiveFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2022. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition
    • Top sections
    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports
    • FT recommends
    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • FTfm
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Community
      • FT Live
      • FT Forums
      • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In